UBS Group’s Oasmia Pharmaceutical AB OASM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,723
| Closed | -$3K | – | 7397 |
|
|
2019
Q2 | $3K | Sell |
2,723
-901
| -25% | -$993 | ﹤0.01% | 6705 |
|
|
2019
Q1 | $8K | Sell |
3,624
-417
| -10% | -$921 | ﹤0.01% | 6146 |
|
|
2018
Q4 | $12K | Buy |
4,041
+1,286
| +47% | +$3.82K | ﹤0.01% | 6246 |
|
|
2018
Q3 | $12K | Buy |
2,755
+1,905
| +224% | +$8.3K | ﹤0.01% | 6171 |
|
|
2018
Q2 | $1K | Sell |
850
-1,723
| -67% | -$2.03K | ﹤0.01% | 6956 |
|
|
2018
Q1 | $3K | Buy |
2,573
+534
| +26% | +$623 | ﹤0.01% | 6582 |
|
|
2017
Q4 | $2K | Sell |
2,039
-1,602
| -44% | -$1.57K | ﹤0.01% | 6680 |
|
|
2017
Q3 | $4K | Sell |
3,641
-3,686
| -50% | -$4.05K | ﹤0.01% | 6428 |
|
|
2017
Q2 | $8K | Buy |
7,327
+7,217
| +6,561% | +$7.88K | ﹤0.01% | 6000 |
|
|
2017
Q1 | $0 | Buy |
+110
| New | – | ﹤0.01% | 6973 |
|
|
2016
Q1 | – | Sell |
-1,900
| Closed | -$7K | – | 7012 |
|
|
2015
Q4 | $7K | Buy |
+1,900
| New | +$7K | ﹤0.01% | 6211 |
|